Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response

Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response

<p>Abstract</p> <p>Background</p> <p>Given the considerable toxicity and modest benefit of adjuvant chemotherapy for non-small cell lung cancer (NSCLC), there is clearly a need for new treatment modalities in the adjuvant setting. Active specific immunotherapy may repre...

Full description

Bibliographic Details
Main Authors: Schendel Dolores J, Wagner Beate, Grützner Stefanie, Pohla Heike, Schlemmer Marcus, Winter Hauke, van den Engel Natasja K, Rüttinger Dominik, Fox Bernard A, Jauch K-W, Hatz Rudolf A
Format: Article
Language:English
Published: BMC 2007-09-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/5/1/43

Internet

http://www.translational-medicine.com/content/5/1/43

Similar Items